Dose-Response Relationships and Pharmacodynamics

Pharmacodynamics studies the relationship between drug concentration and the biological effect it produces. The dose-response relationship, and more fundamentally the concentration-effect relationship, describes how the magnitude of an effect changes as the amount of drug at the site of action increases, typically rising steeply over an intermediate range and then approaching a maximum.

Definition

A dose-response (concentration-effect) relationship is the quantitative association between the amount of drug available to act and the intensity of the resulting effect, commonly described by a sigmoid Emax model characterized by the maximal effect (Emax) and the concentration producing half-maximal effect (EC50).

Scope

This topic covers the shape of the concentration-effect curve, the parameters that describe it (such as the maximal effect and the concentration producing half-maximal effect), the distinction between potency and efficacy, and models that link drug concentration over time to effect over time. It is a reference and educational entry and does not provide dosing or treatment recommendations.

Core questions

• How does the intensity of a drug effect change with concentration at the site of action?
• What parameters summarize a concentration-effect curve?
• How do potency and efficacy differ?
• Why does effect often lag behind plasma concentration, and how is that delay modelled?

Key concepts

• Concentration-effect relationship
• Maximal effect (Emax)
• Half-maximal effective concentration (EC50)
• Potency versus efficacy
• Hill (slope) coefficient
• Hysteresis between concentration and effect
• Therapeutic window

Key theories

Sigmoid Emax (Hill) model

The concentration-effect relationship is commonly represented by a sigmoid function in which effect rises from zero toward a maximum (Emax) as concentration increases, with EC50 marking the half-maximal point and a slope factor describing steepness.

Effect-compartment (link) model

Sheiner and colleagues introduced a hypothetical effect compartment to model the temporal delay between plasma concentration and effect, collapsing the hysteresis loop and enabling simultaneous PK/PD estimation.

Mechanisms

Drug effect arises from interaction with a target, and as concentration at the site of action increases, the effect typically follows a sigmoid curve toward a maximum determined by the number and responsiveness of available targets. The curve is summarized by Emax (the ceiling effect), EC50 (the concentration giving half of Emax, an index of potency), and a slope factor. Because the site of action is often outside the plasma, effect can lag behind plasma concentration, producing a hysteresis loop; effect-compartment models introduce a notional concentration in equilibrium with the effect site to describe this delay and to link pharmacokinetics with pharmacodynamics over time.

Clinical relevance

Concentration-effect relationships explain why both efficacy and adverse effects depend on exposure and why a therapeutic window exists between insufficient and excessive effect. The entry presents these principles for educational reference and is not a basis for selecting doses or individualizing therapy.

Evidence & guidelines

Regulatory agencies provide guidance on exposure-response analysis in drug development, which applies these pharmacodynamic concepts to support dosing decisions during the regulatory process; the foundational theory is summarized in standard pharmacology and pharmacokinetics texts.

History

Quantitative pharmacodynamics grew from receptor-occupancy theory and the application of kinetic ideas to drug effect. Gerhard Levy's analysis of the kinetics of pharmacologic effects connected the time course of concentration to the time course of response, and Sheiner and colleagues' effect-compartment model in 1979 provided a practical way to handle the delay between concentration and effect, establishing the integrated PK/PD modelling now standard in the field.

Key figures

• Gerhard Levy
• Lewis Sheiner
• Stuart Beal
• Malcolm Rowland
• Thomas Tozer

Seminal works

• levy-1966
• sheiner-1979

Frequently asked questions

What is the difference between potency and efficacy?

Efficacy refers to the maximal effect a drug can produce (Emax), while potency refers to the concentration or dose needed to produce a given effect, indexed by EC50; a more potent drug acts at lower concentrations but is not necessarily more efficacious.

Why does drug effect sometimes lag behind plasma concentration?

When the site of action is not the plasma, time is needed for the drug to distribute to and equilibrate with the effect site, producing a delay (hysteresis) that effect-compartment models are designed to describe.